Medicare Enrolled
Dr. Stephanie St Pierre, MD
Dermatology · North Andover, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. St Pierre from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. St Pierre?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. St Pierre
Dr. Stephanie St Pierre is a dermatology specialist in North Andover, MA, with 16 years of NPI registration. Based on federal Medicare data, Dr. St Pierre performed 6,523 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. St Pierre received a total of $12,507 from 42 pharmaceutical and/or device companies across 644 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. St Pierre is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years of NPI registration
▲ Top 10% volume in MA
$12,507 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗6,523
Medicare services
Top 10% in MA for dermatology
Not available
Unique patients (not deduplicated)
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
2,233 | $5 | $36 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,078 | $62 | $303 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
624 | $41 | $270 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
510 | $92 | $432 |
| Ultraviolet light skin treatment Application of ultraviolet light to the skin for therapeutic purposes. |
413 | $19 | $95 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
287 | $70 | $392 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
257 | $84 | $446 |
| Laser treatment for inflammatory skin disease, less than 250 sq cm This procedure uses a laser to treat inflammatory skin conditions covering an area smaller than 250 square centimeters. |
157 | $124 | $690 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
124 | $233 | $1,188 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
77 | $1 | $27 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
74 | $101 | $972 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
72 | $41 | $216 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
72 | $131 | $594 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
72 | $11 | $90 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters. |
69 | $87 | $473 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
66 | $69 | $419 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
63 | $41 | $189 |
| Skin growth shaving, 0.5 cm or less This procedure involves shaving off a small skin growth measuring 0.5 centimeters or less from the body, arms, or legs. |
59 | $65 | $392 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
42 | $128 | $702 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
36 | $31 | $230 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
34 | $115 | $1,107 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
23 | $123 | $635 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters. |
17 | $81 | $567 |
| Removal of noncancer skin growth, 1.1-2.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter. |
16 | $71 | $662 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
13 | $59 | $392 |
| Light therapy to destroy precancerous skin growth This procedure uses light to treat and remove precancerous skin lesions. It is a method for destroying abnormal skin cells before they become cancerous. |
12 | $119 | $500 |
| Topical aminolevulinic acid HCl 20% solution A topical medication applied to the skin for medical treatment. It is supplied as a single-unit dosage form containing 354 mg of the active ingredient. |
12 | $241 | $675 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 11 | $156 | $743 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$12,507
Total received (2018-2024)
Avg $1,787/year across 7 years
Top 14% in MA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
644
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,645
2023
$3,055
2022
$2,455
2021
$852
2020
$670
2019
$1,171
2018
$657
Payments by company (2024)
Janssen Biotech, Inc.
$420
ABBVIE INC.
$417
E.R. Squibb & Sons, L.L.C.
$362
Novartis Pharmaceuticals Corporation
$322
UCB, Inc.
$305
Lilly USA, LLC
$289
GENZYME CORPORATION
$260
PFIZER INC.
$207
SUN PHARMACEUTICAL INDUSTRIES INC.
$199
Dermavant Sciences, Inc.
$197
Arcutis Biotherapeutics, Inc.
$100
LEO Pharma Inc.
$86
Regeneron Healthcare Solutions, Inc.
$75
Celgene Corporation
$75
Galderma Laboratories, L.P.
$71
Boehringer Ingelheim Pharmaceuticals, Inc.
$52
Amgen Inc.
$50
STRATA Skin Sciences, Inc.
$45
REVANCE THERAPEUTICS, INC.
$33
Krystal Biotech Inc
$24
Solta Medical, a division of Bausch Health US, LLC
$22
Sandoz Inc.
$18
Organon Llc
$16
Top 3 companies account for 32.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,241
ABBVIE INC.
$1,200
Janssen Biotech, Inc.
$1,097
GENZYME CORPORATION
$995
Lilly USA, LLC
$936
AbbVie Inc.
$841
PFIZER INC.
$682
UCB, Inc.
$627
Amgen Inc.
$579
E.R. Squibb & Sons, L.L.C.
$556
LEO Pharma Inc.
$508
Sun Pharmaceutical Industries Inc.
$460
Dermavant Sciences, Inc.
$369
Celgene Corporation
$337
SUN PHARMACEUTICAL INDUSTRIES INC.
$307
AbbVie, Inc.
$285
Regeneron Healthcare Solutions, Inc.
$280
Galderma Laboratories, L.P.
$153
Merz North America, Inc.
$153
Boehringer Ingelheim Pharmaceuticals, Inc.
$138
Arcutis Biotherapeutics, Inc.
$100
SANOFI-AVENTIS U.S. LLC
$100
STRATA Skin Sciences, Inc.
$86
Incyte Corporation
$83
Fresenius Kabi USA, LLC
$57
REVANCE THERAPEUTICS, INC.
$33
Mission Pharmacal Company
$32
Organogenesis Inc.
$24
Krystal Biotech Inc
$24
Janssen Scientific Affairs, LLC
$22
Surgical Specialties Corporation (US), Inc.
$22
Solta Medical, a division of Bausch Health US, LLC
$22
Almirall LLC
$20
DERMIRA, INC.
$19
Sandoz Inc.
$18
Verrica Pharmaceuticals Inc.
$17
Organon Llc
$16
Mylan Pharmaceuticals Inc.
$16
Ortho Dermatologics, a division of Bausch Health US, LLC
$15
Merck Sharp & Dohme Corporation
$15
Mayne Pharma Inc.
$11
Biofrontera Inc.
$11
Top 3 companies account for 28.3% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · ALTRENO · AMELUZ · Avar · Bimzelx · COSENTYX · CYLTEZO · Cimzia · DAXXIFY · DORYX · DUPIXENT · ENSTILAR · EPIDUO FORTE · EUCRISA · Enbrel · HADLIMA · HUMIRA · Humira · IDACIO · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · LIBTAYO · OLUMIANT · OPZELURA · ORACEA · Olux · Otezla · Puraply · QBREXZA · REMICADE · RINVOQ · SIVEXTRO · SKYRIZI · SPEVIGO · Seysara · Skyrizi · Sotyktu · Surgical wound closure product · TALTZ · TREMFYA · TWYNEO · Tremfya · VTAMA · VYJUVEK · Winlevi · XEOMIN · XTRAC · YCANTH · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Dermatologists in nearby ZIP areas
331
County median income
$99,431
Nearest hospital to ZIP centroid (approximate)
HOLY FAMILY HOSPITAL
6.5 mi
6.5 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. St Pierre is a clinical cardiology specialist, with above-average Medicare volume (top 10% in MA), with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. St Pierre experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. St Pierre performed 2,233 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. St Pierre receive payments from pharmaceutical companies?
Yes. Dr. St Pierre received a total of $12,507 from 42 companies across 644 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. St Pierre's costs compare to other dermatologists in North Andover?
Dr. St Pierre's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. St Pierre) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in North Andover
Browse dermatologists in North Andover ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in MA
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in MA
Which MA dermatologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology